Oncology Biomarkers Global Market Report 2025

Global Oncology Biomarkers Market Report 2024

Oncology Biomarkers Global Market Report 2025 – By Biomarker Type (Protein Biomarkers, Genetic Biomarkers, Other Cancer Biomarkers), By Profiling Technologies (Omics Technologies, Imaging Technologies, Immunoassay, Bioinformatics, Other Profiling Technologies), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Leukemia, Ovarian Cancer, Liver Cancer, Other Cancer Types), By Application (Diagnostics, Research And Development, Prognostics, Risk Assessment, Other Applications), By End-User (Hospitals, Academic And Cancer Research Institutes, Ambulatory Surgical Centers, Diagnostic Laboratories) – Market Size, Trends, And Global Forecast 2025-2034

Name: Oncology Biomarkers Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Oncology Biomarkers Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Oncology Biomarkers Global Market Report 2025

Proud Members Of

Oncology Biomarkers Market Definition

Oncology biomarkers refer to biological indicators, such as genes, proteins, or other molecules, that can signal the presence of cancer or its progression. They are used to diagnose cancer, predict treatment responses, and monitor disease progression or recurrence. By analyzing these biomarkers, healthcare providers can tailor personalized treatment plans for patients.

The main types of oncology biomarkers are protein biomarkers, genetic biomarkers, and others. Protein biomarkers refer to a single protein or multiple proteins used to diagnose an illness, understand prognosis, and monitor a patient's biological response to treatment. The profiling technologies are omics technologies, imaging technologies, immunoassays, bioinformatics, and others. Cancer types include breast cancer, lung cancer, colorectal cancer, prostate cancer, melanoma, leukemia, ovarian cancer, liver cancer, and others. The various applications are diagnostics, research and development, prognostics, risk assessment, and others, and are mainly used in hospitals, academic and cancer research institutes, ambulatory surgical centers, and diagnostic laboratories.

Oncology Biomarkers Market Segmentation

The oncology biomarkers market covered in this report is segmented –

1) By Biomarker Type: Protein Biomarkers, Genetic Biomarkers, Other Cancer Biomarkers

2) By Profiling Technologies: Omics Technologies, Imaging Technologies, Immunoassay, Bioinformatics, Other Profiling Technologies

3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Leukemia, Ovarian Cancer, Liver Cancer, Other Cancer Types

4) By Application: Diagnostics, Research And Development, Prognostics, Risk Assessment, Other Applications

5) By End-User: Hospitals, Academic And Cancer Research Institutes, Ambulatory Surgical Centers, Diagnostic Laboratories

Subsegments:

1) By Protein Biomarkers: Tumor-Specific Antigens, Circulating Tumor Cells (CTCs), Enzymatic Biomarkers

2) By Genetic Biomarkers: DNA Mutations, Gene Expression Profiles, Single Nucleotide Polymorphisms (SNPs)

3) By Other Cancer Biomarkers: Metabolomic Biomarkers, Epigenetic Biomarkers, MicroRNA Biomarkers

Oncology Biomarkers Market Size and growth rate 2025 to 2029: Graph

Oncology Biomarkers Market Size 2025 And Growth Rate

The oncology biomarkers market size has grown rapidly in recent years. It will grow from $15.3 billion in 2024 to $17.43 billion in 2025 at a compound annual growth rate (CAGR) of 13.9%. The growth in the historic period can be attributed to adoption in emerging economies, precision medicine initiatives, diagnostic innovations, drug development support, increased cancer incidence

Oncology Biomarkers Market Growth Forecast

The oncology biomarkers market size is expected to see rapid growth in the next few years. It will grow to $29.64 billion in 2029 at a compound annual growth rate (CAGR) of 14.2%. The growth in the forecast period can be attributed to integration of next-generation sequencing (ngs), expansion of biomarker informatics, focus on predictive pharmacogenomics, rapid development of exosome-based biomarkers, adoption of spatial transcriptomics. Major trends in the forecast period include standardization and quality assurance, shift towards functional biomarkers, role of biomarkers in clinical trials, expanded applications in immunotherapy, real-time monitoring of treatment responses.

Book your 30 minutes free consultation with our research experts

Oncology Biomarkers Market Driver: Rising Prevalence Of Cancer To Drive Market Growth

The rising incidence of cancer is expected to propel the growth of the oncology biomarker market going forward. Cancer is a disease in which some cells of the body grow uncontrollably and slowly spread to the rest of the body. Oncological biomarkers provide more information about the type of cancer by looking at the genes, proteins, and other substances in a person's body. For instance, in January 2024, according to National Library of Medicine, a US-based government institution, in 2024, it is anticipated that there will be 2,001,140 new cases of cancer and 611,720 cancer-related deaths in the United States. Additionally, the incidence rates for cervical cancer among individuals aged 30 to 44 and colorectal cancer in those under 55 have been rising by 1% to 2% annually among young adults. Therefore, the rising incidence of cancer will drive the oncology biomarker market.

Oncology Biomarkers Market Driver: Rising Adoption Of Personalized Medicine To Drive Market Growth

The increasing adoption of personalized medicine is expected to propel the growth of oncology biomarkers going forward. Personalized medicine is an innovative healthcare approach that tailors medical treatment and interventions to the individual characteristics of each patient. Personalized medicines in the oncology biomarkers market utilize specific biomarkers to identify unique genetic or molecular characteristics of an individual's cancer. For instance, in 2022, according to the Personalized Medicine Coalition, a US-based professional membership organization, the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs) in 2022. Out of the 35 therapeutic NMEs, approximately 34%, which amounts to 12 of them, are classified as personalized medicines by the Personalized Medicine Coalition (PMC). Therefore, the increasing adoption of personalized medicine is driving the growth of oncology biomarkers market.

Global Oncology Biomarkers Market Major Players

Major companies operating in the oncology biomarkers market include F Hoffmann-La Roche AG, Novartis AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Eli Lilly and Company, Merck KGaA, Siemens Healthcare GmbH, Becton Dickinson and Company, GE Healthcare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Hologic Inc., Illumina Inc., Charles River Laboratories International Inc., bioMerieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN NV, Exact Sciences Corporation, Sysmex Corporation, PerkinElmer Inc., Leica Biosystems, Myriad Genetics Inc., Guardant Health Inc., Enzo Biochem Inc., Biocartis Group NV, Bristol-Myers Squibb Company, Agendia Inc., Epigenomics AG, OncoDNA SA

Global Oncology Biomarkers Market Trend: Technological Advancements Driving Innovation In Oncology Biomarkers Market

Adopting innovative and advanced technologies is a key trend in the oncology biomarker market. Major companies in the oncology biomarkers market are introducing new and innovative technologies to strengthen their position in the oncology biomarkers market. For instance, in 2022, OncoDNA, a Belgium-based company focused on precision medicine in oncology, launched OncoDEEP, a unique kit that enables laboratories to perform comprehensive biomarker testing. OncoDEEP uses Next-generation sequencing (NGS) technology and cloud-based software tools to provide laboratories with the ability to perform large-panel sequencing, obtain the molecular characterization of a tumor, analyze the raw data, and access extensive quality controls.

Global Oncology Biomarkers Market Trend: Product Innovations Transforming The Oncology Biomarkers Market

Major companies operating in the oncology biomarkers market are developing new products such as clinical assay to gain a competitive edge in the market. A clinical assay is a biochemical test used in healthcare to measure the presence or amount of a particular substance in a biological sample, such as blood, tissue, or urine. For instance, in December 2022, Adaptive Biotechnologies, a US-based biotechnology company, launched clonoSEQ Assay for detecting minimal residual disease (MRD) in blood for patients with diffuse large B-cell lymphoma (DLBCL). Utilizing circulating tumor DNA (ctDNA), clonoSEQ allows for the assessment of MRD status in DLBCL, offering clinicians a sensitive and quantitative measure of disease burden, enabling earlier relapse detection and facilitating more precise treatment plans. The assay is the first and only MRD test in DLBCL with Medicare coverage across all lines of therapy, treatment regimens, and timepoints, reinforcing its accessibility and impact on patient care.

Oncology Biomarkers Market Merger And Acquisition: Freenome Strengthens Cancer Screening Capabilities With Acquisition Of Oncimmune Ltd.

In May 2023, Freenome, a US-based, privately held biotech company, acquired Oncimmune Ltd. For an undisclosed amount. This acquisition will help Freenome by providing clinical and commercial resources to complement Freenome’s frontline cancer screening efforts. Further, the acquisition will help augment Freenome’s multi-omics platform to capture a more comprehensive view of the tumor microenvironment. Oncimmune Ltd. Is a UK-based company specializing in developing immunodiagnostics, primarily focusing on immune-oncology, autoimmune disorders, and infectious diseases.

Regional Outlook For The Global Oncology Biomarkers Market

North America was the largest region in the oncology biomarkers market in 2024. The regions covered in the oncology biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the oncology biomarkers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

What Defines the Oncology Biomarkers Market?

The oncology biomarkers market consists of sales of epigenetic biomarkers, metabolic biomarkers and proteomic biomarkers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Oncology Biomarkers Industry?

The oncology biomarkers market research report is one of a series of new reports from The Business Research Company that provides oncology biomarkers market statistics, including oncology biomarkers industry global market size, regional shares, competitors with a oncology biomarkers market share, detailed oncology biomarkers market segments, market trends and opportunities, and any further data you may need to thrive in the oncology biomarkers industry. This oncology biomarkers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Oncology Biomarkers Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$17.43 billion
Revenue Forecast In 2034	$29.64 billion
Growth Rate	CAGR of 14.2% from 2024 to 2033
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Biomarker Type: Protein Biomarkers, Genetic Biomarkers, Other Cancer Biomarkers 2) By Profiling Technologies: Omics Technologies, Imaging Technologies, Immunoassay, Bioinformatics, Other Profiling Technologies 3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Leukemia, Ovarian Cancer, Liver Cancer, Other Cancer Types 4) By Application: Diagnostics, Research And Development, Prognostics, Risk Assessment, Other Applications 5) By End-User: Hospitals, Academic And Cancer Research Institutes, Ambulatory Surgical Centers, Diagnostic Laboratories Subsegments: 1) By Protein Biomarkers: Tumor-Specific Antigens, Circulating Tumor Cells (CTCs), Enzymatic Biomarkers 2) By Genetic Biomarkers: DNA Mutations, Gene Expression Profiles, Single Nucleotide Polymorphisms (SNPs) 3) By Other Cancer Biomarkers: Metabolomic Biomarkers, Epigenetic Biomarkers, MicroRNA Biomarkers
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	F Hoffmann-La Roche AG, Novartis AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Eli Lilly and Company, Merck KGaA, Siemens Healthcare GmbH, Becton Dickinson and Company, GE Healthcare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Hologic Inc., Illumina Inc., Charles River Laboratories International Inc., bioMerieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN NV, Exact Sciences Corporation, Sysmex Corporation, PerkinElmer Inc., Leica Biosystems, Myriad Genetics Inc., Guardant Health Inc., Enzo Biochem Inc., Biocartis Group NV, Bristol -Myers Squibb Company, Agendia Inc., Epigenomics AG, OncoDNA SA
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Oncology Biomarkers Market Characteristics

3. Oncology Biomarkers Market Trends And Strategies

4. Oncology Biomarkers Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Oncology Biomarkers Growth Analysis And Strategic Analysis Framework

5.1. Global Oncology Biomarkers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Oncology Biomarkers Market Growth Rate Analysis

5.4. Global Oncology Biomarkers Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Oncology Biomarkers Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Oncology Biomarkers Total Addressable Market (TAM)

6. Oncology Biomarkers Market Segmentation

6.1. Global Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Protein Biomarkers

Genetic Biomarkers

Other Cancer Biomarkers

6.2. Global Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Omics Technologies

Imaging Technologies

Immunoassay

Bioinformatics

Other Profiling Technologies

6.3. Global Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Breast Cancer

Lung Cancer

Colorectal Cancer

Prostate Cancer

Melanoma

Leukemia

Ovarian Cancer

Liver Cancer

Other Cancer Types

6.4. Global Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Diagnostics

Research And Development

Prognostics

Risk Assessment

Other Applications

6.5. Global Oncology Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Academic And Cancer Research Institutes

Ambulatory Surgical Centers

Diagnostic Laboratories

6.6. Global Oncology Biomarkers Market, Sub-Segmentation Of Protein Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tumor-Specific Antigens

Circulating Tumor Cells (CTCs)

Enzymatic Biomarkers

6.7. Global Oncology Biomarkers Market, Sub-Segmentation Of Genetic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

DNA Mutations

Gene Expression Profiles

Single Nucleotide Polymorphisms (SNPs)

6.8. Global Oncology Biomarkers Market, Sub-Segmentation Of Other Cancer Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Metabolomic Biomarkers

Epigenetic Biomarkers

MicroRNA Biomarkers

7. Oncology Biomarkers Market Regional And Country Analysis

7.1. Global Oncology Biomarkers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Oncology Biomarkers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Oncology Biomarkers Market

8.1. Asia-Pacific Oncology Biomarkers Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Oncology Biomarkers Market

9.1. China Oncology Biomarkers Market Overview

9.2. China Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Oncology Biomarkers Market

10.1. India Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Oncology Biomarkers Market

11.1. Japan Oncology Biomarkers Market Overview

11.2. Japan Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Oncology Biomarkers Market

12.1. Australia Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Oncology Biomarkers Market

13.1. Indonesia Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Oncology Biomarkers Market

14.1. South Korea Oncology Biomarkers Market Overview

14.2. South Korea Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Oncology Biomarkers Market

15.1. Western Europe Oncology Biomarkers Market Overview

15.2. Western Europe Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Oncology Biomarkers Market

16.1. UK Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Oncology Biomarkers Market

17.1. Germany Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Oncology Biomarkers Market

18.1. France Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Oncology Biomarkers Market

19.1. Italy Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Oncology Biomarkers Market

20.1. Spain Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Oncology Biomarkers Market

21.1. Eastern Europe Oncology Biomarkers Market Overview

21.2. Eastern Europe Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Oncology Biomarkers Market

22.1. Russia Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Oncology Biomarkers Market

23.1. North America Oncology Biomarkers Market Overview

23.2. North America Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Oncology Biomarkers Market

24.1. USA Oncology Biomarkers Market Overview

24.2. USA Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Oncology Biomarkers Market

25.1. Canada Oncology Biomarkers Market Overview

25.2. Canada Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Oncology Biomarkers Market

26.1. South America Oncology Biomarkers Market Overview

26.2. South America Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Oncology Biomarkers Market

27.1. Brazil Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Oncology Biomarkers Market

28.1. Middle East Oncology Biomarkers Market Overview

28.2. Middle East Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Oncology Biomarkers Market

29.1. Africa Oncology Biomarkers Market Overview

29.2. Africa Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Oncology Biomarkers Market Competitive Landscape And Company Profiles

30.1. Oncology Biomarkers Market Competitive Landscape

30.2. Oncology Biomarkers Market Company Profiles

30.2.1. F Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

31. Oncology Biomarkers Market Other Major And Innovative Companies

31.1. Merck KGaA

31.2. Siemens Healthcare GmbH

31.3. Becton Dickinson and Company

31.4. GE Healthcare Technologies Inc.

31.5. Eurofins Scientific SE

31.6. Agilent Technologies Inc.

31.7. Hologic Inc.

31.8. Illumina Inc.

31.9. Charles River Laboratories International Inc.

31.10. bioMerieux SA

31.11. Bio-Rad Laboratories Inc.

31.12. Bruker Corporation

31.13. QIAGEN NV

31.14. Exact Sciences Corporation

31.15. Sysmex Corporation

32. Global Oncology Biomarkers Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Oncology Biomarkers Market

34. Recent Developments In The Oncology Biomarkers Market

35. Oncology Biomarkers Market High Potential Countries, Segments and Strategies

35.1 Oncology Biomarkers Market In 2029 - Countries Offering Most New Opportunities

35.2 Oncology Biomarkers Market In 2029 - Segments Offering Most New Opportunities

35.3 Oncology Biomarkers Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Oncology Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Oncology Biomarkers Market, Sub-Segmentation Of Protein Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Oncology Biomarkers Market, Sub-Segmentation Of Genetic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Oncology Biomarkers Market, Sub-Segmentation Of Other Cancer Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Oncology Biomarkers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Oncology Biomarkers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: F Hoffmann-La Roche AG Financial Performance

Table 80: Novartis AG Financial Performance

Table 81: Thermo Fisher Scientific Inc. Financial Performance

Table 82: Abbott Laboratories Financial Performance

Table 83: Eli Lilly and Company Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Oncology Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Oncology Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Oncology Biomarkers Market, Sub-Segmentation Of Protein Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Oncology Biomarkers Market, Sub-Segmentation Of Genetic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Oncology Biomarkers Market, Sub-Segmentation Of Other Cancer Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Oncology Biomarkers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Oncology Biomarkers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Oncology Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Oncology Biomarkers Market, Segmentation By Profiling Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Oncology Biomarkers Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: F Hoffmann-La Roche AG Financial Performance

Figure 80: Novartis AG Financial Performance

Figure 81: Thermo Fisher Scientific Inc. Financial Performance

Figure 82: Abbott Laboratories Financial Performance

Figure 83: Eli Lilly and Company Financial Performance

Global Anesthesia Machines Market 2022 – Market Opportunities And Strategies

Latest Benign Prostatic Hyperplasia BPH Treatment Devices And Equipment Market Growth Study 2022-2026 By The Business Research Company

What Is The Computed Tomography CT Scanners Devices And Equipment Market Overview In 2022?

How Will The Laryngoscope Market Grow In 2022?

The Business Research Company offers the single use assemblies market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the temperature monitoring devices market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the urinary incontinence and pelvic organ prolapse devices and equipment market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the dental equipment and supplies market research report 2022 with industry size, share, segments and market growth

Immuno-Oncology Drugs Global Market Report 2025 – By Type (Immune Checkpoint Inhibitors, Immune System Modulators, Other Monoclonal Antibodies, Cancer Vaccines, Others), By Therapeutic Application (Melanoma, Lung Cancer, Blood Cancer, Renal Cell Carcinoma, Bladder Cancer, Other Therapeutic Application), By End-Users (Hospitals, Clinics, Ambulatory Surgical Centers, Others) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Interventional Oncology Devices Global Market Report 2025 – By Product (Embolization Devices, Ablation Devices, Support Devices), By procedure (Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE), Bland Embolization), By Cancer Type (Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Other Cancer Types) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Oncology Biosimilars Global Market Report 2025 – By Drug Type (Monoclonal Antibody, Immunomodulators, Hematopoietic Agents, Granulocyte Colony-Stimulating Factor (G-CSF)), By Cancer Type (Breast Cancer, Colorectal Cancer, Blood Cancer, Neutropenia Cancer, Non-Small Cell Lung Cancer, Other Cancer Types), By Distribution Type (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Oncology Devices Global Market Report 2025 – By Device Type (Brachytherapy Devices, Endoscopic Devices), By Therapy (Chemotherapy, Hormone Therapy, Biotherapy/Immunotherapy, Radiation Therapy), By End User (Hospitals, Cancer Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Oncology Molecular Diagnostics Global Market Report 2025 – By Product (Instruments, Reagents, Other Products), By Technology (Polymerase Chain Reaction (PCR), In-situ Hybridization (ISH), Isothermic Nucleic Acid Amplification Technology (INNAT), Chips & Microarrays, Sequencing, Mass Spectroscopy, Transcription Mediated Amplification (TMA), Other Technologies), By End User (Hospitals, Diagnostic Centers, Academic & Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Clinical Oncology Next Generation Sequencing Global Market Report 2025 – By Technology (Ion Semiconductor Sequencing, Pyro-Sequencing, Synthesis Sequencing, Real Time Sequencing, Ligation Sequencing, Reversible Dye Termination Sequencing, Nano-Pore Sequencing), By Application (Screening, Companion Diagnostics, Other Diagnostics), By End User (Hospital Laboratories, Clinical Research Organizations, Diagnostic laboratories) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Community Oncology Services Global Market Report 2025 – By Type (Small Community Oncology Clinics, Medium Community Oncology Clinics, Large Community Oncology Clinics), By Cancer Type (Breast Cancer, Lung Cancer, Kidney Cancer, Ovarian Cancer, Prostate Cancer, Skin Cancer, Pancreatic Cancer, Blood Cancer, Colorectal Cancer, Other Cancer Types), By Therapy Type (Medical Oncology, Radiation Oncology, Surgical Oncology, Other Therapies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Oncology Nutrition Global Market Report 2025 – By Cancer Type (Blood Cancer, Breast Cancer, Stomach and Gastrointestinal Cancers, Liver Cancer, Pancreatic Cancer, Other Cancer Types ), By Nutrition (Enteral Nutrition, Parenteral Nutrition), By End-Users (Hospitals, Homecare, Specialty Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Oncology Biomarkers market?

How will the Oncology Biomarkers market drivers and restraints affect the market dynamics? What forces will shape the Oncology Biomarkers industry going forward?

The Oncology Biomarkers market major growth driver - Rising Prevalence Of Cancer To Drive Market Growth. For further insights on the Oncology Biomarkers market, request a sample here

What is the forecast market size or the forecast market value of the Oncology Biomarkers market?

The Oncology Biomarkers market size has grown strongly in recent years. The oncology biomarkers market size has grown rapidly in recent years. It will grow from $15.3 billion in 2024 to $17.43 billion in 2025 at a compound annual growth rate (CAGR) of 13.9%. The growth in the historic period can be attributed to adoption in emerging economies, precision medicine initiatives, diagnostic innovations, drug development support, increased cancer incidence The oncology biomarkers market size is expected to see rapid growth in the next few years. It will grow to $29.64 billion in 2029 at a compound annual growth rate (CAGR) of 14.2%. The growth in the forecast period can be attributed to integration of next-generation sequencing (ngs), expansion of biomarker informatics, focus on predictive pharmacogenomics, rapid development of exosome-based biomarkers, adoption of spatial transcriptomics. Major trends in the forecast period include standardization and quality assurance, shift towards functional biomarkers, role of biomarkers in clinical trials, expanded applications in immunotherapy, real-time monitoring of treatment responses. For further insights on the Oncology Biomarkers market, request a sample here

How is the Oncology Biomarkers market segmented?

The oncology biomarkers market covered in this report is segmented –
1) By Biomarker Type: Protein Biomarkers, Genetic Biomarkers, Other Cancer Biomarkers
2) By Profiling Technologies: Omics Technologies, Imaging Technologies, Immunoassay, Bioinformatics, Other Profiling Technologies
3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Leukemia, Ovarian Cancer, Liver Cancer, Other Cancer Types
4) By Application: Diagnostics, Research And Development, Prognostics, Risk Assessment, Other Applications
5) By End-User: Hospitals, Academic And Cancer Research Institutes, Ambulatory Surgical Centers, Diagnostic Laboratories Subsegments:
1) By Protein Biomarkers: Tumor-Specific Antigens, Circulating Tumor Cells (CTCs), Enzymatic Biomarkers
2) By Genetic Biomarkers: DNA Mutations, Gene Expression Profiles, Single Nucleotide Polymorphisms (SNPs)
3) By Other Cancer Biomarkers: Metabolomic Biomarkers, Epigenetic Biomarkers, MicroRNA Biomarkers For further insights on the Oncology Biomarkers market, request a sample here

Which region has the largest share of the Oncology Biomarkers market? What are the other regions covered in the report?

North America was the largest region in the oncology biomarkers market in 2024. The regions covered in the oncology biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the Oncology Biomarkers market, request a sample here.

Who are the major players in the Oncology Biomarkers market?

Major companies operating in the oncology biomarkers market include F Hoffmann-La Roche AG, Novartis AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Eli Lilly and Company, Merck KGaA, Siemens Healthcare GmbH, Becton Dickinson and Company, GE Healthcare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Hologic Inc., Illumina Inc., Charles River Laboratories International Inc., bioMerieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN NV, Exact Sciences Corporation, Sysmex Corporation, PerkinElmer Inc., Leica Biosystems, Myriad Genetics Inc., Guardant Health Inc., Enzo Biochem Inc., Biocartis Group NV, Bristol -Myers Squibb Company, Agendia Inc., Epigenomics AG, OncoDNA SA . For further insights on the Oncology Biomarkers market, request a sample here.

What are the key trends in the Oncology Biomarkers market?

Major trends in the Oncology Biomarkers market include Technological Advancements Driving Innovation In Oncology Biomarkers Market. For further insights on the Oncology Biomarkers market, request a sample here.

What are the major opportunities in the Oncology Biomarkers market? What are the strategies for the Oncology Biomarkers market?

For detailed insights on the major opportunities and strategies in the Oncology Biomarkers market, request a sample here.

How does the Oncology Biomarkers market relate to the overall economy and other similar markets?

For detailed insights on Oncology Biomarkers's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Oncology Biomarkers industry?

For detailed insights on the mergers and acquisitions in the Oncology Biomarkers industry, request a sample here.

What are the key dynamics influencing the Oncology Biomarkers market growth? SWOT analysis of the Oncology Biomarkers market.

For detailed insights on the key dynamics influencing the Oncology Biomarkers market growth and SWOT analysis of the Oncology Biomarkers industry, request a sample here.